Active
Targeted, orally available cancer drugs
USA
Radiation oncology solutions
United Kingdom
Bioinformatics software solutions
Germany
Drugs against hormone-dependent diseases such as breast cancer
Germany
Commercial stage osteoporosis drug
Switzerland
Selective TGF-β oligonucleotide inhibitors
Germany
T cell-based research tools, contract research and diagnostics
Germany
Switzerland
-
Diagnostic platforms and focused therapies for cancer patients
Germany
Orthopaedic and trauma surgery solutions
Germany
Drug discovery and development services
Germany
Therapeutic proteins
USA
Hepatitis C drug
USA
Exited
.
Natural product small molecules and analogues libraries
Germany
Exit 2013
Peripheral balloon catheters
Ireland
Exit 2018
-
-
Drugs against cancer
USA
Exit 2013
-
-
Fluorescent dyes
Germany
Exit 2009
-
-
Molecular biology databases and tools
Germany
Exit 2012
Non-invasive vagus-nerve stimulation device against epilesy
Germany
Exit 2018
-
-
Chiral intermediates
Germany
Exit 2008
-
-
Medical devices for treatment of heart failure
Israel
Exit 2015
Metabolic disorders
Germany
Exit 2009
-
-
-
Totally implantable hearing aid
USA
Exit 2007
-
-
Vital signs monitors
Germany
Exit 2007
-
-
-
Drugs against cancer
and screening services
France
Exit 2009 (IPO)
-
-
Drugs against cancer
USA
Exit 2007 ("cold" IPO)
Cancer diagnostics
Germany
Exit 2018
Pain treatment devices
USA
Exit 2019
Ophthalmic diseases
USA
Exit 2016
Drugs against inflammatory and hermatological diseases
Germany
Exit 2007
Drugs against infectious diseases
USA
Exit 2014 (IPO)
Drugs against angiogenesis-related disorders
Italy
Exit 2013
Orthopaedics for children
Germany
Exit 2017
-
-
Chromatographic devices (HPLC)
Germany
Exit 2012